News
Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS).
Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback